The NTAGI today approved Serum Institute of India’s Covovax for the 12-17 age group, according to sources. There has also not been any decision by NTAGI on vaccinating 5-12 year olds. Meanwhile the government also plans to expedite the process of recognition of Covid-19 vaccine Corbevax by other countries. Stay with TOI for latest updates: